Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 3/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | GGT1 | P19440 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28885229 | 0.98 | TSHR (0.38) | TSHRALDH1A1PPARACYP4F2CYP4A11 | |
| SCHEMBL30227255 | 0.81 | ALDH1A1 (0.39) | TSHRALDH1A1HMGCRCHRM1TBXA2R | |
| SCHEMBL7932802 | 0.80 | PPARA (0.41) | TSHRALDH1A1PPARACYP4F2CYP4A11 | |
| SCHEMBL30227097 | 0.77 | ALDH1A1 (0.41) | TSHRALDH1A1PPARAPPARG | |
| SCHEMBL5843703 | 0.76 | NAAA (0.41) | TSHR | |
| Acetic Acid SCHEMBL28275735 | 0.75 | FFAR3 (0.37) | TSHRALDH1A1PPARACYP4F2CYP4A11 | |
| SCHEMBL15645230 | 0.73 | PPARA (0.33) | TSHRALDH1A1PPARACYP4F2CYP4A11 | |
| SCHEMBL1487661 | 0.72 | TSHR (0.33) | TSHRPPARA | |
| 2-Methoxyethanol SCHEMBL6368510 | 0.71 | ALDH1A1 (0.52) | TSHRALDH1A1PPARAHMGCRCHRM1 | |
| SCHEMBL7207097 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190016856-A1 | MULTI-ARMED POLYETHYLENE GLYCOL AND ACTIVE DERIVATIVE THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2019-01-17 | — | — | US | disclosed |
| US-7935776-B2 | having a carboxy group in its main chain and a acryloyl group in its side chain; Color filters | AGI CORPORATION (TW) | 2011-05-03 | — | — | US | disclosed |
| US-20080234403-A1 | Radiation curable and developable polyurethane and radiation curable and developable photo resist composition containing the same | AGI CORPORATION (TW) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190016856-A1 | MULTI-ARMED POLYETHYLENE GLYCOL AND ACTIVE DERIVATIVE THEREOF | COG2, PTGER2, MGLL | TSHR 4417/4885ALDH1A1 1584/4885PPARA 2507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.